Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 28.3B | 14.5B | 26.9B | 25.9B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3.9B | -3.2B | 3.4B | 2.9B |
Other operating expenses | 1.9B | -9.8B | 1.6B | 1.5B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 22.7B | 18.5B | 20.2B | 20.9B |
Tax provision | 6.1B | 5.6B | 5.4B | 5.3B |
Net income | 16.6B | 12.9B | 14.8B | 15.6B |
Basic EPS | 5.5 | — | 4.9 | 5.2 |
Diluted EPS | 5.4 | — | 4.8 | 5.1 |
Basic average shares | 151.7B | — | 151.2B | 151.2B |
Diluted average shares | 153.0B | — | 153.1B | 153.1B |
EBITDA | — | — | — | — |
Net income from continuing op. | 22.7B | 18.5B | 20.2B | 20.9B |
Minority interests | -1.4M | -60.4M | 377K | 124K |
Preferred stock dividends | — | — | — | — |